Brought to you by 
Carmat SAS grosses €15.5mm through its IPO
27 Apr 2012
Executive Summary
Two-year-old artificial heart developer Carmat SAS has grossed €15.5mm ($19.6mm) through the initial public offering of 827k shares (including the option clause) at €18.75 (mid-way between its proposed €17.35-20.15 range) on the Alternext of NYSE Euronext Paris. The company had hoped to bring in up to €19.8mm.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com